top of page
  • Writer's pictureNisarg Patel

Role of Dexamethasone in hospitalised patients in Covid-19.

A study was conducted to determine whether dexamethasone, a steroid, could reduce mortality in hospitalized Covid-19 patients by reducing lung damage caused by inflammation. The study involved randomly assigning patients to receive either dexamethasone or usual care. The primary outcome was 28-day mortality. The study found that patients who received dexamethasone had a lower mortality rate than those who received usual care, especially among patients who required respiratory support at the time of randomization. Specifically, patients who received invasive mechanical ventilation or oxygen alone had a lower mortality rate than those who received usual care. However, patients who did not require respiratory support did not show a significant difference in mortality between the two groups. The study was funded by various organizations and registered under and ISRCTN.

0 views0 comments

Recent Posts

See All

Although HIV cannot be cured, highly effective treatments are available that allow most people with the virus to live a long and healthy life. In the event of possible exposure to HIV, post-exposure p

Cord blood banking is a rapidly growing industry in India, with 15 private banks offering the service of harvesting and storing cord blood for future use. Cord blood contains stem cells similar to tho

Navigating the world of pharmacology can be overwhelming for healthcare providers and patients alike due to the vast number of brand name and generic drugs available. While patients may be prescribed

bottom of page